Annemarie Moseley, COO/EVP Clinical Development at BELLICUM PHARMACEUTICALS, INC (BLCM), sold 32,700 shares at $19.01 ($622K) on 2016-01-04, disclosed to the SEC on 2016-01-06.
Open-market sale of $622k BLCM by COO/EVP Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| BLCM | SELL | 2016-06-06 | $325K | — | Filing → |
| BLCM | SELL | 2016-01-06 | $713K | — | Filing → |
| BLCM | SELL | 2015-07-06 | $722K | — | Filing → |